How Much Does Compounded Semaglutide Cost? What Drives the Number

This article does not tell you what compounded semaglutide or tirzepatide costs, and that is deliberate. Sellers change figures weekly, so any number written into a sentence here would be wrong before you read it. What does not change is the shape of the bill: the handful of ways a headline figure turns out not to be the amount you keep paying. Learn those, then get the current numbers from our live price tracker, where each one carries the date we captured it.

Seven ways an advertised figure is not the standing one

Each of these is something we have had to record while building the register. None is exotic and most are perfectly legal. They are simply arithmetic that happens somewhere other than the headline.

The dose ladder is not an accident, and neither is the price ladder

GLP-1 dosing starts low on purpose and rises on a schedule. Both approved semaglutide labels hold the opening four weeks at a 0.25 mg weekly dose; Wegovy injection then titrates every four weeks toward a usual maintenance dosage of 2.4 mg weekly, and Ozempic steps up to a maintenance dosage of 0.5 mg, 1 mg or 2 mg, with 2 mg once weekly stated as the maximum recommended.^[6][7] Whatever a compounded program is doing, it is doing it against that same clinical pattern of escalation.

So a price attached to a starting strength is a price for the part of treatment you spend the least time in. Ask what the figure becomes at each rung, not what it is today. A program that will not answer that in writing has answered something else.

What the FTC has already said about this pattern

In July 2025 the Federal Trade Commission announced a settlement with the operators of a telehealth weight-loss company over how its programs were sold. The allegation at the center of it is the second mechanism in the table above: memberships advertised at a monthly price without adequately disclosing that the price did not cover the GLP-1 drug itself, the lab work needed to establish eligibility, or the consultation required to get a prescription.^[2]

The complaint went further into the terms. The FTC alleged the programs carried a required one-year commitment with early termination fees that was not adequately disclosed, that cancellation and refund requests went unresolved because the company had not staffed to handle them, and that it did not obtain informed consent before charging people.^[2] The proposed order bars misrepresenting the cost of telehealth services, including what that cost covers and the timing or manner of any charge, and requires refund and cancellation terms to be disclosed clearly before a consumer is asked to pay.^[2] The final order was approved in December 2025.^[1]

What legitimately differs between sellers

Not every gap between two quotes is a trick. Three real differences move the number, and it is worth knowing which one you are looking at before deciding a seller is expensive.

The dose

Strength is the difference most likely to explain an honest gap. Two programs quoting different figures may simply be quoting different rungs of the ladder. A comparison only means something at the same dose, which is why our boards record the strength alongside the figure rather than ranking headline numbers against each other.

What is inside the price

The consultation, follow-up visits, the lab panel, shipping, and the syringes and needles are each sometimes included and sometimes billed on their own. A quote that covers all of them is not comparable to one that covers the drug alone, and the difference is frequently larger than the gap between the two headline figures.

503A or 503B

A traditional pharmacy compounding under section 503A prepares a drug on receipt of a prescription for an individual patient. An outsourcing facility registered under section 503B operates under current good manufacturing practice requirements, is inspected by FDA on a risk-based schedule, and has to report adverse events.^[3] Those are different cost structures, and they also carry different amounts of public evidence. Neither is FDA-approved: the agency does not review any compounded drug for safety, effectiveness or quality before it reaches a patient.^[3] Which facility made your vial is a question with an answer, and our pharmacy register is where we keep those answers.

One more variable, and it is legal rather than commercial

The compounded market's cheapest years ran on a shortage. FDA set the end of its enforcement discretion for compounded semaglutide at April 22, 2025 for state-licensed pharmacies and May 22, 2025 for outsourcing facilities, and as of its April 1, 2026 update neither semaglutide nor tirzepatide appears on the 503B bulks list or on the drug shortage list.^[4] A seller still offering these at scale should be able to say what it is relying on, and that is a fair question to ask alongside the price. We set out the rule in which GLP-1s can be compounded and the reader's options in what to do when a compounded program ends.

A quote well below everything else in the market is worth pausing on for the same reason. FDA lists medicine offered at deep discounts, or at prices that look too good to be true, among its telehealth warning signs.^[5] We treat an unusually low capture as a likely error in our own process until we have reproduced it, and sometimes it is exactly that.

Ask these before you pay

1. Is the figure I am seeing the renewal figure? If not, what is the renewal figure, in writing?
2. How often will my card be charged, and on what cycle? Every four weeks and once a calendar month are not the same commitment.
3. Does this cover the medication itself? Ask separately about the consultation, follow-ups, lab work, shipping and injection supplies.
4. What am I committing to? Minimum term, early termination fee, and what happens to money already paid if I stop.
5. How do I cancel, and how long does it take? A regulator has already brought a case where the answer to that was the problem.^[2]
6. What does this cost at the next dose, and the one after? Get the whole ladder, not the rung you start on.^[6]
7. Which pharmacy compounds it, 503A or 503B? The answer sets the manufacturing standard behind your vial.^[3]
8. What is the concentration, and how many doses is one vial at my strength? That converts a per-vial figure into something you can compare.

If a program will not put those answers in writing before payment, that is information about the program. Take the answers you do get and check them against the dated figures on our price tracker and the compounded semaglutide board.